252P Real-world progression-free survival (rwPFS) and time to next line of therapy (TTNT) as intermediate endpoints for survival in metastatic breast cancer: A real-world experience.
Saved in:
| Title: | 252P Real-world progression-free survival (rwPFS) and time to next line of therapy (TTNT) as intermediate endpoints for survival in metastatic breast cancer: A real-world experience. |
|---|---|
| Authors: | Labaki, C.1 (AUTHOR), Bakouny, Z.2 (AUTHOR), Sanglier, T.3 (AUTHOR), Schmidt, A.4 (AUTHOR), Shim, J.5 (AUTHOR), Braun, D.A.6 (AUTHOR), Bouquet, F.7 (AUTHOR), Joyce, M.8 (AUTHOR), Xie, W.1 (AUTHOR), Tolaney, S.M.1 (AUTHOR), Choueiri, T.K.9 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS652-S652. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2022.07.291 |
